Publication:
Pulsed radiotherapy to mitigate high tumor burden and generate immune memory

Thumbnail Image

Organizational Units

Program

KU-Authors

KU Authors

Co-Authors

Barsoumian, H.B.
He, K.
Hu, Y.
Wang, Q.
Abana, C.O.
Puebla-Osorio, N.
Hsu, E.Y.
Wasley, M.
Masrorpour, F.
Wang, J.

Advisor

Publication Date

2022

Language

English

Type

Journal Article

Journal Title

Journal ISSN

Volume Title

Abstract

Radiation therapy (XRT) has a well-established role in cancer treatment. Given the encouraging results on immunostimulatory effects, radiation has been increasingly used with immune-check-point inhibitors in metastatic disease, especially when immunotherapy fails due to tumor immune evasion. We hypothesized that using high-dose stereotactic radiation in cycles (pulses) would increase T-cell priming and repertoire with each pulse and build immune memory in an incremental manner. To prove this hypothesis, we studied the combination of anti-CTLA-4 and Pulsed radiation therapy in our 344SQ non-small cell lung adenocarcinoma murine model. Primary and secondary tumors were bilaterally implanted in 129Sv/Ev mice. In the Pulsed XRT group, both primary and secondary tumors received 12Gyx2 radiation one week apart, and blood was collected seven days afterwards for TCR repertoire analysis. As for the delayed-Pulse group, primary tumors received 12Gyx2, and after a window of two weeks, the secondary tumors received 12Gyx2. Blood was collected seven days after the second cycle of radiation. The immunotherapy backbone for both groups was anti-CTLA-4 antibody to help with priming. Treatment with Pulsed XRT + anti-CTLA-4 led to significantly improved survival and resulted in a delayed tumor growth, where we observed enhanced antitumor efficacy at primary tumor sites beyond XRT + anti-CTLA-4 treatment group. More importantly, Pulsed XRT treatment led to increased CD4+ effector memory compared to single-cycle XRT. Pulsed XRT demonstrated superior efficacy to XRT in driving antitumor effects that were largely dependent on CD4+ T cells and partially dependent on CD8+ T cells. These results suggest that combinatorial strategies targeting multiple points of tumor immune evasion may lead to a robust and sustained antitumor response.

Description

Source:

Frontiers in Immunology

Publisher:

Frontiers

Keywords:

Subject

Immunology

Citation

Endorsement

Review

Supplemented By

Referenced By

Copy Rights Note

1

Views

0

Downloads

View PlumX Details